Status: Recruiting
A Study to Evaluate Effects on Sleep and Safety of RE03 in PTSD Patients With Sleep Disturbances
Post-traumatic stress disorder (PTSD) affects many people who have experienced traumatic events. A common issue with PTSD is severe sleep disturbances, such as nightmares. Current treatments often do not provide sufficient relief, especially for sleep problems. This study aims to determine whether dexmedetomidine - a medication already used in intensive care - can improve sleep quality in PTSD patients.
Participants needed: 24
Trial details
Phase: Phase 2Age: 18-64Biological sex: AllType: InterventionalSponsor: Reconnect LabsUpdated: Sep 16, 2025Locations: 1
Eligibility criteria
Male or female, aged ≥18 and ≤64 years (inclusive) [+5]
Inability to comply with sleep-wake schedule related study requirements, e.g. du... [+38]